Evidence map›Paper›PMID 35558104›Full record

ArticleFrontiers in microbiology2022

Pilot Investigation of SARS-CoV-2 Variants in the Island of Sicily Prior to and in the Second Wave of the COVID-19 Pandemic.

Miguel Padilla-Blanco, Francesca Gucciardi, Annalisa Guercio, Vicente Rubio, Antonina Princiotta, Veronica Veses, Mariangela Terrana, Chirag C Sheth, Marina Pascual-Ortiz, Elisa Maiques and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Miguel Padilla-BlancoDepartment of Pharmacy, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Francesca GucciardiIstituto Zooprofilattico Sperimentale della Sicilia "A. Mirri", Palermo, Italy.
Annalisa GuercioIstituto Zooprofilattico Sperimentale della Sicilia "A. Mirri", Palermo, Italy.
Vicente RubioInstituto de Biomedicina de Valencia (IBV-CSIC), CIBER of Rare Diseases (CIBERER-ISCIII), Valencia, Spain.
Antonina PrinciottaIstituto Zooprofilattico Sperimentale della Sicilia "A. Mirri", Palermo, Italy.
Veronica VesesDepartment of Biomedical Sciences, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Mariangela TerranaIstituto Zooprofilattico Sperimentale della Sicilia "A. Mirri", Palermo, Italy.
Chirag C ShethDepartment of Medicine, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Marina Pascual-OrtizDepartment of Biomedical Sciences, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Elisa MaiquesDepartment of Biomedical Sciences, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Giuseppa PurpariIstituto Zooprofilattico Sperimentale della Sicilia "A. Mirri", Palermo, Italy.
Consuelo Rubio-GuerriDepartment of Pharmacy, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Valencia, Spain.
Universidad Cardenal Herrera CEU · ESIstituto Zooprofilattico Sperimentale Della Sicilia · ITCentre for Biomedical Network Research on Rare Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After 2 years of the COVID-19 pandemic, we continue to face vital challenges stemming from SARS-CoV-2 variation, causing changes in disease transmission and severity, viral adaptation to animal hosts, and antibody/vaccine evasion. Since the monitoring, characterization, and cataloging of viral variants are important and the existing information on this was scant for Sicily, this pilot study explored viral variants circulation on this island before and in the growth phase of the second wave of COVID-19 (September and October 2020), and in the downslope of that wave (early December 2020) through sequence analysis of 54 SARS-CoV-2-positive samples. The samples were nasopharyngeal swabs collected from Sicilian residents by a state-run one-health surveillance laboratory in Palermo. Variant characterization was based on RT-PCR amplification and sequencing of four regions of the viral genome. The B.1.177 variant was the most prevalent one, strongly predominating before the second wave and also as the wave downsized, although its relative prevalence decreased as other viral variants, particularly B.1.160, contributed to virus circulation. The occurrence of the B.1.160 variant may have been driven by the spread of that variant in continental Europe and by the relaxation of travel restrictions in the summer of 2020. No novel variants were identified. As sequencing of the entire viral genome in Sicily for the period covered here was restricted to seven deposited viral genome sequences, our results shed some light on SARS-CoV-2 variant circulation during that wave in this insular region of Italy which combines its partial insular isolation with being a major entry point for the African immigration.

Indexed as

B.1.160 variantB.1.177 variantCOVID-19 in autumn 2020SARS-CoV-2Sicily (Italy)

Identifiers

PMID35558104
PMCPMC9087553
OpenAlexW4225009080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.